This is the authors' abstract. We don't add key points for this paper.
Importance Coronavirus disease 2019 (COVID-19) is a newly emerging infectious disease with a global pandemic. The presenting symptoms are mainly respiratory symptom, yet studies have reported nervous system involvement in the disease. A systematic review and meta-analysis of these studies are required to understanding the neurologic characteristic of the disease and help physicians for early diagnosis and management Objective To conduct a systematic review and meta-analysis on the neurologic characteristics in patients with COVID-19. Evidence Review Authors conducted a literature search through PubMed from January 1st, 2020 to April 8th, 2020. Furthermore, the authors added additional sources by reviewing related references. Studies presenting the neurologic features of COVID-19 patients in their data were included. Case reports and case series also included in this review. The quality of the studies was assessed based on the Oxford Centre for Evidence-Based Medicine guidelines. Selected studies were included in the meta-analysis of proportion and heterogeneity test. Finding From 280 identified studies, 33 were eligible, with 7559 participants included. Most of the included studies were from China (29[88%]). Muscle injury or myalgia was the most common (19.2%, 95%CI 15.4 – 23.2%) neurologic symptoms of COVID-19, followed by headache (10.9%, 95%CI 8.62 – 13.51%); dizziness (8.7%, 95%CI 5.02 – 13.43%); nausea with or without vomiting (4.6%, 95%CI 3.17 – 6.27%); concurrent cerebrovascular disease (4.4%, 95%CI 1.92 – 7.91%); and impaired consciousness (3.8%, 95%CI 0.16 – 12.04%). Underlying cerebrovascular disease was found in 8.5% (95%CI 4.5 – 13.5%) of the studies. Conclusion Neurologic findings are various from nonspecific to specific symptoms in COVID-19 patients. Some severe symptoms or diseases can present in the later stage of the disease. Physicians should be aware of the presence of neurologic signs and symptoms as a chief complaint of COVID-19, in order to improve management and prevent worsening outcome of the patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Pinzon et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: